bAdjusted for age (continuous, years), sex, smoking history, eGFR (categorical, <30, 30-60, ≥60), post-transplant RDW (continuous, %), hypoalbuminemia (categorical, serum albumin <3.0 g/dL), presence of acute rejection (within post-TPL 3 month), baseline diabetes mellitus, hypertension, whether induction therapy was performed, medication use of tacrolimus, donor relationship (deceased). This evidence concerns the gene ALB and hypertensive disorder.